Drug intelligence / Profile preview

GenSci164

Development stage
Phase 1
Lead developer
Changchun GeneScience Pharmaceutical
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

GenSci164 is a biological therapeutic candidate developed by Changchun GeneScience Pharmaceutical (GenSci) for the treatment of hypoparathyroidism. As a biological product designed for subcutaneous injection, it likely functions as an agonist of the parathyroid hormone receptor, aiming to restore calcium and phosphate homeostasis in patients with deficient endogenous parathyroid hormone levels. The drug is currently undergoing early-stage clinical evaluation, including a Phase 1 randomized, double-blind, placebo-controlled dose-escalation study in healthy Chinese adults to assess its safety, tolerability, pharmacokinetics, and pharmacodynamics.

Other names
GenSci164 injectionGenSci-164 injectionGenSci 164 injection
02

Targets

PTH1R (Parathyroid hormone/Parathyroid hormone-related peptide receptor type 1)

Beyond the preview

Go deeper on GenSci164.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenSci164.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call